• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Monday, January 30, 2023
Montgomery County News Online
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
No Result
View All Result
Home Technology Gaming

Technology Being Challenged By Upsurge In Decentralized Clinical Trials – 69News WFMZ-TV

technology-being-challenged-by-upsurge-in-decentralized-clinical-trials-–-69news-wfmz-tv
Share on FacebookShare on Twitter

As new non-COVID-related clinical trials proliferate, the need for effective global decentralized CT management is becoming even more apparent. What is needed, says Dr. Harsha Rajasimha of Jeeva Informatics, is to expand the capabilities of validated and human-centric digital technology.

, /PRNewswire-PRWeb/ — Clinical trials in certain common serious diseases are on track for their first year-over-year increase since the outbreak of the COVID-19 pandemic. Among areas slated for significantly increased testing are diabetes, hypertension, and respiratory tract infection. Along with these activities will come a marked increase in decentralized clinical trial design, expected to increase 28% this year over 2021.(1) “By joining forces to enable the increased growth of decentralized studies,” says Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics, “technology companies are transforming the face of medical research. The remotely managed, decentralized clinical trial is the wave of the future.”

One reason for this, notes Dr. Rajasimha, is the ongoing lack of diversity among patients participating in traditionally structured clinical trials. Historically, clinical trials have tended to take place in close proximity to major medical research organizations; some 50% of FDA trials are conducted in one to two percent of all US zip codes,(2) leading to under-representation of members of racial or ethnic minorities.(3) The solution, says Dr. Rajasimha, is to allow socio-economically and geographically diverse patients to participate in clinical trials independent of their location via a modular and flexible bring-your-own-device solution.

There has been, he notes, a growing awareness of the need for decentralized clinical trials for some time. A few years back, for example, the National Academies of Sciences convened a forum on transforming clinical trials through technology. Various speakers took note that:

  •     The traditional research model requires a massive investment of resources before acquiring any feedback on study viability.
  •     New technology such as wearable devices, remote monitoring, and virtual clinical visits could make Clinical Trials more patient-focused.
  •     Social media offer increased opportunities for patient engagement.(4)

For decentralized clinical trials to work effectively, however, says Dr. Rajasimha, it is necessary for the various technologies involved to work together effectively. Companies like Jeeva Informatics are developing the next generation of virtual platform technology that gives sponsors and CROs, greater flexibility with a modular eClinical platform for global trial operations.

Lessons learned

  •     Over the course of the COVID-19 pandemic, says Dr. Rajasimha, it has become clear in a number of ways that remote access to clinical trials is essential.
  •     The pandemic has made many prospective enrollees unable or unwilling to travel to a hospital or other major medical facility to participate in a new drug study.
  •     A large percentage of CTs will experience delays, costing the developers as much as $1 million per day.(5)
  •     Traditional trials have led to a serious lack of diversity.
  •     The accelerated process used for COVID-19 trials has conclusively demonstrated both the need for and the efficacy of decentralized clinical trials.

Technology platforms partnered with a systems integrator, says Dr. Rajasimha, can accelerate data collection and provide both better integration of the disparate software and data systems involved and platform-level unification of the entire CT process. What is needed, he says, is the ability to knit patient outcomes—from virtually any device—into an integrated 360o view.

In fact, adds Rajasimha, the last few years have seen an enormous increase in how technology is applied to clinical trials. The use of Artificial Intelligence technology in matching patients to clinical trials, in diagnostic devices, the proliferation of smartphone use in clinical data-capture, cloud services to store and access to Electronic Medical Records and “many more examples have led to one inescapable conclusion: clinical trials can now be conducted entirely in a virtual format.” There are many challenges still to conquer, Rajasimha notes, but eliminating the need for in-person interaction coupled with real-time access to data are encouraging news for the future of clinical trials.

“On one level,” says Dr. Rajasimha, “a clinical trial is a one-off project—a test of the response of X subjects to Y treatment. On another level, however, it needs to be a comprehensive digital data collection and processing platform. Being a part of the Amazon Partner Network (APN) and a recent partnership with a global IT systems integrator, enables us to achieve both data collection and process unification, thus delivering dramatic improvements in cost- and performance-effectiveness to the sponsors of clinical trials.”

About Jeeva Informatics

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

1.    Castañeda, et al. “2022 Forecast: Diabetes, Cardiovascular, Respiratory Trial Activity Set to Rebound.” Clinical Trials Arena, 3 Feb. 2022, clinicaltrialsarena.com/analysis/2022-clinical-trials-diabetes-cardiovascular-disease-among-likely-winners/.

2.    “Clinical Trials Have Far Too Little Racial and Ethnic Diversity.” Scientific American, 1 Sept. 2018, scientificamerican.com/article/clinical-trials-have-far-too-little-racial-and-ethnic-diversity/.

3.    “Why We Need to Improve Diversity in Clinical Trial Participants.” Mdgroup, 18 Dec. 2021, mdgroup.com/blog/why-we-need-to-improve-diversity-amongst-clinical-trial-participants/#:

4.    Forum on Neuroscience and Nervous System Disorders. “Transforming Clinical Trials with Technology.” Neuroscience Trials of the Future: Proceedings of a Workshop., U.S. National Library of Medicine, 19 Aug. 2016, ncbi.nlm.nih.gov/books/NBK396107/.

5.    “How to Avoid Costly Clinical Research Delays: Blog.” MESM, mesm.com/blog/tips-to-help-you-avoid-costly-clinical-research-delays/.

Media Contact

Karla Jo Helms, JoTo PR, 727-777-4619, mradmin@jotopr.com

Twitter

SOURCE Jeeva Informatics

rt

Montgomery County News Online

© 2021 Montgomery County News Online

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Montgomery County News Online

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT